title: [European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. CEIPC 2008 Spanish adaptation].
abstract: The present CEIPC Spanish adaptation of the European Guidelines on Cardiovascular Disease Prevention in Clinical Practice 2008. This guide recommends the SCORE model for risk evaluation. The aim is to prevent premature mortality and morbidity due to CVD by means of dealing with its related risk factors in clinical practice. The guide focuses on primary prevention and emphasizes the role of the nurses and primary care doctors in promoting a healthy life style, based on increasing physical activity, changing dietary habits, and not smoking. The therapeutic goal is to achieve a Blood Pressure < 140/90 mmHg, but in patients with diabetes, chronic kidney disease, or definite CVD, the objective is < 130/80 mmHg. Serum cholesterol should be < 200 mg/dl and cLDL < 130 mg/dl, although in patients with CVD or diabetes, the objective is < 100 mg/dl (80 mg/dl if feasible in very high-risk patients). Patients with type 2 diabetes and those with metabolic syndrome must lose weight and increase their physical activity, and drugs must be administered whenever applicable, with the objective guided by body mass index and waist circumference. In diabetic type 2 patients, the objective is glycated haemoglobin < 7%. Allowing people to know the guides and developing implementation programs, identifying barriers and seeking solutions for them, are priorities for the CEIPC in order to put the recommendations into practice.
authors.affiliation: Sociedad Española de Medicina de Familia y Comunitaria, España. jmlobos@telefonica.net
authors.forename: J M
authors.initials: JM
authors.lastname: Lobos
authors.forename: M A
authors.initials: MA
authors.lastname: Royo-Bordonada
authors.forename: C
authors.initials: C
authors.lastname: Brotons
authors.forename: L
authors.initials: L
authors.lastname: Alvarez-Sala
authors.forename: P
authors.initials: P
authors.lastname: Armario
authors.forename: A
authors.initials: A
authors.lastname: Maiques
authors.forename: D
authors.initials: D
authors.lastname: Mauricio
authors.forename: S
authors.initials: S
authors.lastname: Sans
authors.forename: F
authors.initials: F
authors.lastname: Villar
authors.forename: A
authors.initials: A
authors.lastname: Lizcano
authors.forename: A
authors.initials: A
authors.lastname: Gil-Núñez
authors.forename: F
authors.initials: F
authors.lastname: de Alvaro
authors.forename: P
authors.initials: P
authors.lastname: Conthe
authors.forename: E
authors.initials: E
authors.lastname: Luengo
authors.forename: A
authors.initials: A
authors.lastname: Del Río
authors.forename: O
authors.initials: O
authors.lastname: Cortés
authors.forename: A
authors.initials: A
authors.lastname: de Santiago
authors.forename: M A
authors.initials: MA
authors.lastname: Varga
authors.forename: M
authors.initials: M
authors.lastname: Martínez
authors.forename: V
authors.initials: V
authors.lastname: Lizarbe
mesh_terms: D001519:Behavior; D002318:Cardiovascular Diseases / Q000097:blood / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control* / Q000523:psychology / Q000628:therapy; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000628:therapy; D012307:Risk Factors; D012959:Socioeconomic Factors; D013030:Spain